JB/PUT/DOTTIKON ES N/230/0.01/21.06.24 Stock

Warrant

DEYPJB

CH1311822774

Market Closed - Swiss Exchange 11:20:00 2024-05-15 EDT
0.04 CHF -20.00% Intraday chart for JB/PUT/DOTTIKON ES N/230/0.01/21.06.24
Current month-63.64%
1 month-75.00%
Date Price Change
24-05-15 0.04 -20.00%

Delayed Quote Swiss Exchange

Last update May 15, 2024 at 11:20 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying DOTTIKON ES HOLDING AG
Issuer Bank Julius Bär
DEYPJB
ISINCH1311822774
Date issued 2023-12-20
Strike 230 CHF
Maturity 2024-06-21 (32 Days)
Parity 100 : 1
Emission price 0.24 CHF
Emission volume N/A
Settlement both
Currency CHF

Technical Indicators

Highest since issue 0.33 CHF
Lowest since issue 0.04 CHF
Spread 0.01 CHF
Spread %20.00%

Company Profile

Dottikon ES Holding AG is a Switzerland-based holding company that specializes in hazardous chemistry and focuses on the exclusive synthesis of fine chemicals for the pharmaceutical and chemical industries. Its product range includes active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, as well as industrial chemicals. Its pharmaceutical products can be found in medications for, among others, heart disease, asthma, high blood pressure and ulcers. Dottikon ES Holding AG's industrial end products include food additives, cosmetics, electro-chemicals, photo-chemicals and agricultural chemicals. The Company also offers distillation plants and thin layer evaporators for the recycling of solvents, as well as high temperature incinerators for the waste treatment of hazardous waste. As of March 31, 2012, the Company had two wholly owned subsidiaries: DOTTIKON EXCLUSIVE SYNTHESIS AG and DOTTIKON ES MANAGEMENT AG. It also held a 33.9%-stake in SYSTAG, System Technik AG.
Sector
-
More about the company

Consensus: Dottikon ES Holding AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
252
Average target price
-
Consensus
  1. Stock Market
  2. Warrants
  3. DEYPJB Warrant
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW